Tadashi Hirose
Directeur/Bestuurslid bij Prolexys Pharmaceuticals, Inc.
Profiel
Tadashi Hirose is a Director of Prolexys Pharmaceuticals, Inc. He is President of the Corporate Ventures Catalyst Division for Hitachi America Ltd.
and President of the Corporate Ventures Capital Office of Hitachi Ltd.
Prior to his current position at Hitachi, he was Senior Researcher of Systems Development Laboratory, Department Manager of the Information Systems Group, the Information and Telecom Systems Group, and Senior Vice President of Hitachi Computer America Ltd.
He joined Hitachi in April 1975.
Mr. Hirose received a BS degree in Instrumental and System Control Engineering and an MS degree in Mathematical Programming from Keio University in Japan.
Actieve functies van Tadashi Hirose
| Bedrijven | Functie | Begin |
|---|---|---|
Prolexys Pharmaceuticals, Inc.
 Prolexys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prolexys Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering small molecule drugs that act at novel therapeutic targets. The Company's therapeutic focus is on cancer and cardiovascular indications. Prolexys scientists have exploited proprietary proteomics-related techniques to rapidly and accurately identify drug candidates that interact with targets of interest. The result of targeted drug discovery work at Prolexys is a pipeline of product candidates with high value in areas of unmet medical need. Lead programs include: a) Solid tumor oncology program with a small molecule clinical candidate with selective anti-tumor activity, b) The colon cancer program with novel small molecule compounds targeting the beta-catenin signaling cascade and c) HSP20 antagonists, identified as protein interaction inhibitors from targets validated in asthma and vasorelaxation. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Tadashi Hirose
| Bedrijven | Functie | Einde |
|---|---|---|
| HITACHI, LTD. | Corporate Officer/Principal | - |
Opleiding van Tadashi Hirose
| Keio University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| HITACHI, LTD. | Producer Manufacturing |
| Bedrijven in privébezit | 1 |
|---|---|
Prolexys Pharmaceuticals, Inc.
Prolexys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prolexys Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering small molecule drugs that act at novel therapeutic targets. The Company's therapeutic focus is on cancer and cardiovascular indications. Prolexys scientists have exploited proprietary proteomics-related techniques to rapidly and accurately identify drug candidates that interact with targets of interest. The result of targeted drug discovery work at Prolexys is a pipeline of product candidates with high value in areas of unmet medical need. Lead programs include: a) Solid tumor oncology program with a small molecule clinical candidate with selective anti-tumor activity, b) The colon cancer program with novel small molecule compounds targeting the beta-catenin signaling cascade and c) HSP20 antagonists, identified as protein interaction inhibitors from targets validated in asthma and vasorelaxation. | Health Technology |
